PERSPECTA

News from every angle

← Back to headlines

Advancements in Personalized Cancer Immunotherapy Vaccines

Research indicates that a single universal cancer vaccine is unlikely, with the focus shifting towards personalized vaccines tailored to each patient and tumor. BriaCell is advancing a personalized melanoma immunotherapy vaccine candidate, Bria-MEL+™.

24 Aug, 16:25 — 24 Aug, 16:25
PostShare

Sources

Showing 1 of 2 sources
EL PAISMostly Factual12h ago

There won’t be a single cancer vaccine, but rather a different one for each patient and tumor

After decades of setbacks, a treatment for melanoma is very close to being approved

By Daniel Mediavilla

Read full article →

Coverage Timeline

First report: taiwan-news · 24 Aug, 11:30Full coverage: 2 · 5hWindow: 5h
Left-leaningCenterRight-leaning
taiwan-news24 Aug, 11:30First to report

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ - Taiwan News

5h later
EL PAIS24 Aug, 16:25Latest update

There won’t be a single cancer vaccine, but rather a different one for each patient and tumor

Related Stories

Study Links Breakfast Timing to Lifespan

1h ago

Exploring Mental Health and Wellness Beyond Traditional Therapy, Including Sound Therapy

4h ago

Health Company Admits Maradona Test Mix-Up in Death Trial

5h ago

FDA Clears Roche and Eli Lilly's Alzheimer's Blood Test

7h ago